ALTERATIONS IN AFFERENT PATHWAYS FROM THE URINARY-BLADDER OF THE RAT IN RESPONSE TO PARTIAL URETHRAL OBSTRUCTION
ALTERATIONS IN AFFERENT PATHWAYS FROM THE URINARY-BLADDER OF THE RAT IN RESPONSE TO PARTIAL URETHRAL OBSTRUCTION
复制标题
DOI:
10.1002/cne.903100309
复制
发表时间:
1991-08-15
影响因子:
2.5
通讯作者:
DEGROAT, WC
中科院分区:
文献类型:
--
作者:
STEERS, WD;CIAMBOTTI, J;DEGROAT, WC
Afferent pathways from the urinary bladder were examined with axonal tracing techniques in normal female Wistar rats and in those with partial urethral ligation. Following injection of wheat germ agglutinin-horseradish peroxidase (HRP) into the bladder wall, HRP was detected in lumbosacral dorsal root ganglion cells and in afferent projections to the L6-S1 spinal cord at sites in laminae I, II, V-VII, and X known to receive visceral afferent input. Partial urethral ligation (6 weeks) produced a sixfold increase in bladder weight and altered the morphology of bladder afferent pathways. Changes included an increase in the average cross-sectional area of labelled neuronal profiles in L6 and S1 dorsal root ganglia in obstructed (766 +/- 378-mu-m2, P < 0.001) compared to control rats (528 +/- 189-mu-2). The cross-sectional area of the largest profiles also increased by approximately 40%. The mean number of labelled dorsal root ganglion cell profiles was similar in ligated (837 +/- 198) and control (883 +/- 352) groups. When compared to control animals the obstructed animals exhibited a 60% increase in the area of the labelled afferent terminal field in the intermediolateral region of the L6-S1 spinal cord. This increased labelling was even more remarkable given that the volume of tracer per bladder weight injected into the hypertrophied bladder was 87% less than controls. These results provide evidence that bladder afferents project to regions of the spinal cord known to regulate micturition and that these afferents can undergo morphological alterations and/or changes in axoplasmic transport in response to urethral ligation. Changes may occur in response to increased target organ mass, increased neural activity, or alterations in the levels or activity of neurotrophic factors.